Arlinda Lee
Stock Analyst at Canaccord Genuity
(1.34)
# 3,632
Out of 5,154 analysts
41
Total ratings
36.59%
Success rate
-0.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arlinda Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $9.08 | +131.28% | 3 | Sep 7, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $600 → $300 | $3.76 | +7,878.72% | 3 | Apr 5, 2022 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $375 → $90 | $70.70 | +27.30% | 5 | Mar 16, 2022 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $45 → $36 | $93.52 | -61.51% | 3 | Mar 7, 2022 | |
| CELC Celcuity | Initiates: Buy | $50 | $115.00 | -56.52% | 1 | Oct 8, 2021 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $151 → $160 | $56.50 | +183.19% | 3 | Aug 16, 2021 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $36 → $40 | $5.20 | +669.23% | 3 | Jul 15, 2021 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $92 → $105 | $21.25 | +394.12% | 12 | Oct 29, 2020 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $23 → $27 | $67.37 | -59.92% | 3 | May 19, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Buy | $50 | $2.15 | +2,225.58% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $8.77 | +2,978.68% | 3 | Nov 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $160 | $0.25 | +63,594.27% | 1 | Mar 29, 2018 |
Delcath Systems
Sep 7, 2023
Maintains: Buy
Price Target: $18 → $21
Current: $9.08
Upside: +131.28%
X4 Pharmaceuticals
Apr 5, 2022
Maintains: Buy
Price Target: $600 → $300
Current: $3.76
Upside: +7,878.72%
Nektar Therapeutics
Mar 16, 2022
Maintains: Buy
Price Target: $375 → $90
Current: $70.70
Upside: +27.30%
Rhythm Pharmaceuticals
Mar 7, 2022
Maintains: Buy
Price Target: $45 → $36
Current: $93.52
Upside: -61.51%
Celcuity
Oct 8, 2021
Initiates: Buy
Price Target: $50
Current: $115.00
Upside: -56.52%
CRISPR Therapeutics AG
Aug 16, 2021
Maintains: Buy
Price Target: $151 → $160
Current: $56.50
Upside: +183.19%
Bicycle Therapeutics
Jul 15, 2021
Maintains: Buy
Price Target: $36 → $40
Current: $5.20
Upside: +669.23%
Ultragenyx Pharmaceutical
Oct 29, 2020
Maintains: Buy
Price Target: $92 → $105
Current: $21.25
Upside: +394.12%
Halozyme Therapeutics
May 19, 2020
Maintains: Buy
Price Target: $23 → $27
Current: $67.37
Upside: -59.92%
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Buy
Price Target: $50
Current: $2.15
Upside: +2,225.58%
Nov 5, 2019
Maintains: Buy
Price Target: $225 → $270
Current: $8.77
Upside: +2,978.68%
Mar 29, 2018
Maintains: Buy
Price Target: $300 → $160
Current: $0.25
Upside: +63,594.27%